Cargando…
Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells
BACKGROUND: Ovarian cancer is the most common cause of cancer related death from gynecologic tumors in the United States. The insidious nature of the disease precludes early diagnosis, therefore surgical debulking and chemotherapy are considered as standard treatment modalities for advanced stages....
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890636/ https://www.ncbi.nlm.nih.gov/pubmed/20504359 http://dx.doi.org/10.1186/1757-2215-3-13 |